The Latest Breaking News from HTG Molecular Diagnostics

12 Health Care Stocks Moving In Friday's Intraday Session

 

Benzinga · Jul 22, 2022

5 Short Squeeze Candidates To Watch This Week: Singing Machine And Revlon Top The List, Chicken Soup For Soul Rejoins

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

Benzinga · Jul 18, 2022

HTG Molecular Diagnostics's Return On Capital Employed Insights

HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $1.18 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 25.16%, resulting in a loss of $6.50 million.

Benzinga · Jun 17, 2022

Looking Into HTG Molecular Diagnostics's Return On Capital Employed

HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $2.88 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.6%, resulting in a loss of $5.19 million.

Benzinga · Mar 30, 2022

Earnings Preview: HTG Molecular Diagnostics

HTG Molecular Diagnostics (NASDAQ:HTGM) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that HTG Molecular Diagnostics will report an earnings per share (EPS) of $-0.59.

Benzinga · Mar 28, 2022

Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 112 stocks made new 52-week lows.

Benzinga · Mar 24, 2022